TRAPPC13
Trafficking protein particle complex subunit 13
Also known as: C5orf44, FLJ13611, MGC48585, TPC13_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A5PLN9
- Gene
- TRAPPC13
- Ensembl
- ENSG00000113597
- Chromosome
- 5
- Canonical length
- 417 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport; vesicle coating; and vesicle tethering. Predicted to be located in cytosol. Predicted to be part of TRAPPIII protein complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
417 residues, UniProt reviewed canonical sequence.
>A5PLN9|TRAPPC13
1 MEVNPPKQEH LLALKVMRLT KPTLFTNIPV TCEEKDLPGD LFNQLMRDDP STVNGAEVLM
61 LGEMLTLPQN FGNIFLGETF SSYISVHNDS NQVVKDILVK ADLQTSSQRL NLSASNAAVA
121 ELKPDCCIDD VIHHEVKEIG THILVCAVSY TTQAGEKMYF RKFFKFQVLK PLDVKTKFYN
181 AESDLSSVTD EVFLEAQIQN MTTSPMFMEK VSLEPSIMYN VTELNSVSQA GECVSTFGSR
241 AYLQPMDTRQ YLYCLKPKNE FAEKAGIIKG VTVIGKLDIV WKTNLGERGR LQTSQLQRMA
301 PGYGDVRLSL EAIPDTVNLE EPFHITCKIT NCSERTMDLV LEMCNTNSIH WCGISGRQLG
361 KLHPSSSLCL ALTLLSSVQG LQSISGLRLT DTFLKRTYEY DDIAQVCVVS SAIKVESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAPPC13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 21 nTPM
- kidney: 19 nTPM
- prostate: 18 nTPM
- thyroid gland: 16 nTPM
- heart muscle: 16 nTPM
- tongue: 16 nTPM
Single-cell type
- sertoli cells: 87 nCPM
- myonuclei: 78 nCPM
- oligodendrocytes: 75 nCPM
- lactotrophs: 70 nCPM
- corticotrophs: 69 nCPM
- somatotrophs: 68 nCPM
Immune cell
- basophil: 18 nTPM
- non-classical monocyte: 13 nTPM
- MAIT T-cell: 11 nTPM
- T-reg: 9.4 nTPM
- intermediate monocyte: 9.3 nTPM
- total PBMC: 9.1 nTPM
Brain region
- white matter: 15 nTPM
- hypothalamus: 12 nTPM
- spinal cord: 12 nTPM
- cerebellum: 12 nTPM
- midbrain: 11 nTPM
- pons: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.8
- DepMap mean gene effect
- -0.36
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Trafficking protein particle complex subunit 13
- Trafficking protein particle complex subunit 13, N-terminal
- Trafficking protein particle complex subunit 13, C-terminal
- Trafficking protein particle complex subunit 13, middle domain
- Trafficking protein particle complex subunit 13, N-terminal
- Trafficking protein particle complex subunit 13, C-terminal
- Trafficking protein particle complex subunit 13, middle domain
InteractionsUniProt · HPA
Protein binding partners of TRAPPC13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAPPC13 as an antibody target. Whether an autoantibody or antibody against TRAPPC13 could matter depends on whether native TRAPPC13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAPPC13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAPPC13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...